Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-17-013109
Filing Date
2017-05-15
Accepted
2017-05-15 16:37:54
Documents
2
Period of Report
2017-05-04

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 20162
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 5330
  Complete submission text file 0000899243-17-013109.txt   27206
Mailing Address 19 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 19 FIRSTFIELD ROAD GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Issuer) CIK: 0001326190 (see all company filings)

EIN.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 19 FIRSTFIELD ROAD SUITE 200 GAITHERSBURG MD 20878
Business Address 5 RUE DE LA BAUME PARIS I0 75008 (240) 654-1450
Truffle Capital S.A.S. (Reporting) CIK: 0001706034 (see all company filings)

State of Incorp.: I0 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-32587 | Film No.: 17844950